Bo Yang1, Himanshu J Patel2, Elizabeth L Norton2, Christina Debenedictus3, Linda Farhat2, Xiaoting Wu2, Kevin He4, Whitney E Hornsby5, Donald S Likosky2, G Michael Deeb2. 1. Department of Cardiac Surgery, Michigan Medicine, Ann Arbor, Michigan. Electronic address: boya@med.umich.edu. 2. Department of Cardiac Surgery, Michigan Medicine, Ann Arbor, Michigan. 3. University of Michigan Medical School, Ann Arbor, Michigan. 4. Department of Biostatistics, University of Michigan, Ann Arbor, Michigan. 5. Department of Internal Medicine, Michigan Medicine, Ann Arbor, Michigan.
Abstract
BACKGROUND: Limited data are available regarding outcomes for stentless aortic valve reoperation. The reported reoperative mortality has been unacceptably high. METHODS: Between 1997 and 2017, a retrospective analysis was performed on 143 patients who underwent open aortic valve reoperations for failed stentless aortic valve bioprostheses. We evaluated both short-term and long-term outcomes on this cohort of patients. RESULTS: Bicuspid aortic valve was present in 107 of 143 patients (75%) at the time of the initial Freestyle (Medtronic, Minneapolis, MN) procedure, and 120 of 143 patients (84%) underwent a modified inclusion aortic root replacement procedure. The interval from first operation to reoperation was 9 years (range, 5.4 to 11.8), which was significantly shorter for patients with infectious endocarditis (4.1 years; range, 1.8 to 7.1) compared with patients with structural valvular deterioration (10.4 years; range, 8.1 to 12.4, p < 0.001). The median age at the time of reoperation was 59 years (range, 50 to 67). Aortic valve reoperation was performed for structural valve deterioration in 68% cases compared with 32% for infectious prosthetic valve endocarditis. Concomitant surgery included coronary artery bypass (13%), mitral valve surgery (4%), and ascending aorta and arch replacement (42%). The 30-day and inhospital mortality was 1% and 2%, respectively. The composite outcome including myocardial infarction, stroke, new-onset renal failure on hemodialysis, and operative mortality was 4%. The 5-year and 10-year Kaplan-Meier survival after reoperation for failed stentless valve was 83% (95% confidence interval: 73% to 89%) and 57% (95% confidence interval: 36% to 74%). CONCLUSIONS: Aortic valve reoperation after stentless valve implantation can be performed with low operative mortality and favorable long-term survival.
BACKGROUND: Limited data are available regarding outcomes for stentless aortic valve reoperation. The reported reoperative mortality has been unacceptably high. METHODS: Between 1997 and 2017, a retrospective analysis was performed on 143 patients who underwent open aortic valve reoperations for failed stentless aortic valve bioprostheses. We evaluated both short-term and long-term outcomes on this cohort of patients. RESULTS:Bicuspid aortic valve was present in 107 of 143 patients (75%) at the time of the initial Freestyle (Medtronic, Minneapolis, MN) procedure, and 120 of 143 patients (84%) underwent a modified inclusion aortic root replacement procedure. The interval from first operation to reoperation was 9 years (range, 5.4 to 11.8), which was significantly shorter for patients with infectious endocarditis (4.1 years; range, 1.8 to 7.1) compared with patients with structural valvular deterioration (10.4 years; range, 8.1 to 12.4, p < 0.001). The median age at the time of reoperation was 59 years (range, 50 to 67). Aortic valve reoperation was performed for structural valve deterioration in 68% cases compared with 32% for infectious prosthetic valve endocarditis. Concomitant surgery included coronary artery bypass (13%), mitral valve surgery (4%), and ascending aorta and arch replacement (42%). The 30-day and inhospital mortality was 1% and 2%, respectively. The composite outcome including myocardial infarction, stroke, new-onset renal failure on hemodialysis, and operative mortality was 4%. The 5-year and 10-year Kaplan-Meier survival after reoperation for failed stentless valve was 83% (95% confidence interval: 73% to 89%) and 57% (95% confidence interval: 36% to 74%). CONCLUSIONS: Aortic valve reoperation after stentless valve implantation can be performed with low operative mortality and favorable long-term survival.
Authors: John Pepper; Davy Cheng; Rex Stanbridge; Francis D Ferdinand; W R Eric Jamieson; Paul Stelzer; Geoffrey Berg; Guido Sani; Janet Martin Journal: Innovations (Phila) Date: 2009-03
Authors: Michael A Borger; Kriengchai Prasongsukarn; Susan Armstrong; Christopher M Feindel; Tirone E David Journal: Ann Thorac Surg Date: 2007-09 Impact factor: 4.330
Authors: M R Moon; D C Miller; K A Moore; P E Oyer; R S Mitchell; R C Robbins; E B Stinson; N E Shumway; B A Reitz Journal: Ann Thorac Surg Date: 2001-04 Impact factor: 4.330
Authors: Tirone E David; Gheorghe Gavra; Christopher M Feindel; Tommaso Regesta; Susan Armstrong; Manjula D Maganti Journal: J Thorac Cardiovasc Surg Date: 2006-11-30 Impact factor: 5.209
Authors: Bo Yang; Aroosa Malik; Linda Farhat; Alexander Makkinejad; Elizabeth L Norton; Mohamed-Ali Sareini; Emma St Pierre; Xiaoting Wu; Jonathan Haft; Matthew Romano; Steven F Bolling; Himanshu J Patel; G Michael Deeb Journal: Ann Thorac Surg Date: 2019-12-23 Impact factor: 4.330
Authors: Reilly D Hobbs; Elizabeth L Norton; Xiaoting Wu; Cristen J Willer; Scott L Hummell; Richard L Prager; Jonathan Afilalo; Whitney E Hornsby; Bo Yang Journal: J Thorac Cardiovasc Surg Date: 2020-05-23 Impact factor: 5.209
Authors: Adriaan W Schneider; Mark G Hazekamp; Michel I M Versteegh; Arend de Weger; Eduard R Holman; Robert J M Klautz; Eline F Bruggemans; Jerry Braun Journal: Eur J Cardiothorac Surg Date: 2019-12-01 Impact factor: 4.191
Authors: Bailey Brown; Tan Le; Aroma Naeem; Aroosa Malik; Elizabeth L Norton; Xiaoting Wu; Himanshu J Patel; G Michael Deeb; Karen M Kim; Bo Yang Journal: JTCVS Open Date: 2021-09-28